Edition:
United States

People: Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

347.50DKK
16 Aug 2019
Change (% chg)

kr.4.60 (+1.34%)
Prev Close
kr.342.90
Open
kr.339.60
Day's High
kr.347.70
Day's Low
kr.338.40
Volume
3,385,624
Avg. Vol
2,459,338
52-wk High
kr.349.70
52-wk Low
kr.265.15

Mackay, Martin 

Dr. Martin Mackay, Ph.D. has been Independent Director of NOVO NORDISK A/S since March 22, 2018. He is Chairman of the Research & Development Committee. He co-founded Rallybio LLC, US, in January 2018 and serves as chair of the board and in an executive leadership role overseeing all research and non-research functions. He is Senior Advisor to New Leaf Venture Partners, LLC, US and Member of the board of Charles River Laboratories International, Inc., US. He holds Doctorate/PhD from University of Edinburgh, UK (1984), BSc (First Class Honours) in Microbiology from Heriot-Watt University, Edinburgh, UK (1979).

Basic Compensation

Total Annual Compensation, DKK 1,200,000
Restricted Stock Awards, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 1,200,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --